Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jan;111(1):370–376. doi: 10.1111/j.1476-5381.1994.tb14070.x

Attenuated 5-hydroxytryptamine receptor-mediated responses in aortae from streptozotocin-induced diabetic rats.

G M James 1, W C Hodgson 1, E A Davis 1, J M Haynes 1
PMCID: PMC1910015  PMID: 8012721

Abstract

1. This study was designed to examine further the attenuated contractile responses to 5-hydroxytryptamine (5-HT) previously observed in aortae from diabetic rats. 2. Cumulative concentration-response curves to 5-HT, and the 5-HT receptor agonists, alpha-methyl 5-HT (alpha-Me-5-HT, 5-HT2/1C agonist), (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane (DOI, 5-HT2/1C agonist) and 5-carboxamidotryptamine (5-CT, 5-HT1A/1B/1D agonist), were examined in endothelium-intact and -denuded aortae from 2-week streptozotocin (STZ)-diabetic and control rats. 3. In endothelium-intact and -denuded aortae from diabetic rats, maximum responses to 5-HT and alpha-Me-5-HT were significantly reduced compared to those of aortae from control rats. Responses to these agonists were inhibited by the 5-HT2/1C receptor antagonist, ketanserin (0.1 microM). 4. The attenuated responses to 5-HT of aortae from diabetic rats were normalized by chronic insulin treatment of the rats (5 units day-1, s.c.), but not by altering the glucose concentration of the bathing fluid. 5. The nitric oxide synthase inhibitor N-nitro-L-arginine (NOLA, 0.1 mM) significantly potentiated responses to both 5-HT and alpha-Me-5-HT in endothelium-intact aortae. However, the difference between maximum responses of aortae from diabetic and control rats was still evident in the presence of NOLA. 6. Endothelium-intact rings, in the presence of ketanserin (0.1 microM) and preconstricted with the thromboxane A2-mimetic, U46619 (0.1-0.3 microM), from control and diabetic rats, did not relax to cumulative additions of 5-HT (1 nM-30 microM).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A. 5-HT receptors in the coronary circulation. Trends Pharmacol Sci. 1989 Mar;10(3):89–90. doi: 10.1016/0165-6147(89)90197-1. [DOI] [PubMed] [Google Scholar]
  2. Chaouloff F., Laude D., Baudrie V. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat. Eur J Pharmacol. 1990 Oct 23;187(3):435–443. doi: 10.1016/0014-2999(90)90370-l. [DOI] [PubMed] [Google Scholar]
  3. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  4. Cohen M. L., Fuller R. W., Wiley K. S. Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther. 1981 Aug;218(2):421–425. [PubMed] [Google Scholar]
  5. Feniuk W., Humphrey P. P., Perren M. J., Watts A. D. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol. 1985 Nov;86(3):697–704. doi: 10.1111/j.1476-5381.1985.tb08948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fulton D. J., Hodgson W. C., Sikorski B. W., King R. G. Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 1991 Dec;104(4):928–932. doi: 10.1111/j.1476-5381.1991.tb12528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hagen A. A., Shirasawa Y., White R. P. Experimental diabetes: reduction of serotonin-induced vasoconstriction by meclofenamic acid in vitro. Pharmacology. 1985;30(4):197–204. doi: 10.1159/000138069. [DOI] [PubMed] [Google Scholar]
  8. Head R. J., Longhurst P. A., Panek R. L., Stitzel R. E. A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol. 1987 Jun;91(2):275–286. doi: 10.1111/j.1476-5381.1987.tb10282.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henseling M. Accumulation of 3H-(-)noradrenaline in the rabbit aorta not related to uptake1 and uptake2, but sensitive to 3,4-dihydroxy-2-methylpropiophenone (U-0521) and oxytetracycline. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(2):121–127. doi: 10.1007/BF00634259. [DOI] [PubMed] [Google Scholar]
  10. Hodgson W. C., King R. G. Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozotocin-induced diabetic rats. Br J Pharmacol. 1992 Jul;106(3):644–649. doi: 10.1111/j.1476-5381.1992.tb14389.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoyer D., Vos P., Closse A., Pazos A., Palacios J. M., Davies H. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):226–230. doi: 10.1007/BF00172788. [DOI] [PubMed] [Google Scholar]
  12. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol. 1989 Jun;97(2):614–618. doi: 10.1111/j.1476-5381.1989.tb11993.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leysen J. E., Niemegeers C. J., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982 Mar;21(2):301–314. [PubMed] [Google Scholar]
  14. Martin W., Furchgott R. F., Villani G. M., Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1986 May;237(2):529–538. [PubMed] [Google Scholar]
  15. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  16. Nakaki T., Roth B. L., Chuang D. M., Costa E. Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C. J Pharmacol Exp Ther. 1985 Aug;234(2):442–446. [PubMed] [Google Scholar]
  17. Owen M. P., Carrier G. O. Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes. Proc West Pharmacol Soc. 1979;22:363–366. [PubMed] [Google Scholar]
  18. Oyama Y., Kawasaki H., Hattori Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 1986 Dec 2;132(1):75–78. doi: 10.1016/0014-2999(86)90013-0. [DOI] [PubMed] [Google Scholar]
  19. Schacterle G. R., Pollack R. L. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem. 1973 Feb;51(2):654–655. doi: 10.1016/0003-2697(73)90523-x. [DOI] [PubMed] [Google Scholar]
  20. Sikorski B. W., James G. M., Glance S. D., Hodgson W. C., King R. G. Effect of endothelium on diabetes-induced changes in constrictor responses mediated by 5-hydroxytryptamine in rat aorta. J Cardiovasc Pharmacol. 1993 Sep;22(3):423–430. doi: 10.1097/00005344-199309000-00012. [DOI] [PubMed] [Google Scholar]
  21. Vargas H. M., Ignarro L. J., Chaudhuri G. Physiological release of nitric oxide is dependent on the level of vascular tone. Eur J Pharmacol. 1990 Nov 13;190(3):393–397. doi: 10.1016/0014-2999(90)94204-b. [DOI] [PubMed] [Google Scholar]
  22. Vo P. A., Reid J. J., Rand M. J. Endothelial nitric oxide attenuates vasoconstrictor responses to nerve stimulation and noradrenaline in the rat tail artery. Eur J Pharmacol. 1991 Jun 18;199(1):123–125. doi: 10.1016/0014-2999(91)90647-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES